How many drugs treat Weight loss?

Drug Landscape tracks 6 marketed treatments for Weight loss (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

What's the most recent regulatory action in Weight loss?

Most recent: Saxenda — FDA approved.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/weight-loss.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Weight loss — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Weight loss (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Weight loss, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Ozempic	semaglutide	Novo Nordisk	GLP-1 Receptor Agonist [EPC]	GLP-1 receptor	2017-01-01
Victoza	liraglutide	Novo Nordisk	GLP-1 Receptor Agonist [EPC]	Glucagon-like peptide 1 receptor
Liraglutid	Liraglutid	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School		Glucagon-like peptide 1 receptor
Saxenda	Saxenda	Seoul National University Hospital		Glucagon-like peptide 1 receptor
Victoza	Victoza	Hanmi Pharmaceutical Company Limited		Glucagon-like peptide 1 receptor
Rybelsus	Rybelsus	Pfizer		Glucagon-like peptide 1 receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

2026-03-30 — Saxenda · FDA · approved · US

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 2 drugs in Weight loss
Novo Nordisk · 2 drugs in Weight loss
Hanmi Pharmaceutical Company Limited · 1 drug in Weight loss
Pfizer · 1 drug in Weight loss
Seoul National University Hospital · 1 drug in Weight loss
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · 1 drug in Weight loss

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Weight loss:

Cite this brief

Drug Landscape (2026). Weight loss — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/weight-loss. Accessed 2026-06-10.

Weight loss full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing